Compare MCBS & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MCBS | CBLL |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 935.3M |
| IPO Year | 2019 | 2024 |
| Metric | MCBS | CBLL |
|---|---|---|
| Price | $34.85 | $24.53 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $33.00 | $23.20 |
| AVG Volume (30 Days) | 54.6K | ★ 274.5K |
| Earning Date | 04-24-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.63% | N/A |
| EPS Growth | 4.76 | ★ 56.93 |
| EPS | ★ 1.53 | N/A |
| Revenue | N/A | ★ $89,063,000.00 |
| Revenue This Year | $36.78 | $29.57 |
| Revenue Next Year | $2.44 | $28.44 |
| P/E Ratio | $22.80 | ★ N/A |
| Revenue Growth | N/A | ★ 36.09 |
| 52 Week Low | $24.53 | $10.85 |
| 52 Week High | $37.46 | $25.63 |
| Indicator | MCBS | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 57.45 |
| Support Level | $34.42 | $23.01 |
| Resistance Level | $35.30 | $25.09 |
| Average True Range (ATR) | 0.55 | 0.81 |
| MACD | -0.02 | -0.16 |
| Stochastic Oscillator | 32.45 | 56.82 |
MetroCity Bankshares Inc is a bank holding company. Through its banking subsidiary, it operates as a full-service commercial bank focused on delivering various financial products and services to the small-to medium-sized businesses and individuals in its markets, including many customers in diverse and multi-ethnic communities in metropolitan markets in the Eastern U.S., Texas and California. The company provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers, and a variety of other banking services. The majority of its revenue is generated in the form of interest income.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.